Evaluation of changes in mammographic breast density associated with bazedoxifene, raloxifene, and placebo in postmenopausal women: an ancillary study of protocol 3068A1-301-WW

Trial Profile

Evaluation of changes in mammographic breast density associated with bazedoxifene, raloxifene, and placebo in postmenopausal women: an ancillary study of protocol 3068A1-301-WW

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2010

At a glance

  • Drugs Bazedoxifene; Raloxifene
  • Indications Menopause
  • Focus Pharmacodynamics
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 17 Aug 2010 Actual end date changed from Sep 2007 to Apr 2010 as reported by ClinicalTrials.gov.
    • 04 Dec 2007 Status change from in progress to completed.
    • 18 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top